NCT05864274
Improve Cancer-related Cognitive Impairment
StatusActive, Not Recruiting
PhaseNot applicable
Primary completion (estimated)
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 11 versions: 11 with changes below. See every version on ClinicalTrials.gov ↗
- Notable Eligibility criteria expanded, about 6 words
- Enrollment closed, study ongoing
- Study description revised
- Site details revised
- Notable Trial status: Active, Not Recruiting to Recruiting
- Primary and study completion dates: Aug 1, 2026 to Aug 1, 2027
- Site details revised
- Notable Primary and study completion dates: Aug 1, 2025 to Aug 1, 2026v9
- Minor Trial status: Not Yet Recruiting to Active, Not Recruiting
- Study sites: 0 to 1
- Start date changed from estimate of Aug 1, 2024 to Sep 1, 2024
- Interventions: Cognitive training application (Behavioral) to Cognitive training application (Device)
- Notable Start date: Jul 1, 2024 to Aug 1, 2024v7
Show 5 earlier versionsHide 5 earlier versions
- Notable Start date: May 1, 2024 to Jul 1, 2024v6
- Notable Start date: Feb 1, 2024 to May 1, 2024v5
- Notable Start date: Dec 1, 2023 to Feb 1, 2024v4
- Notable Start date: Oct 1, 2023 to Dec 1, 2023v3
- Notable Start date: Aug 1, 2023 to Oct 1, 2023v2
- Study First Submitted
- Notable: the plan changed
- Minor: routine updates
Endpoints
Primary
Neurocognitive function
Timeframe: From initiation of chemotherapy through 2 years
Arms and interventions
OBSERVATIONNo intervention
PATIENTS WILL PARTICIPATE IN THE NEUROPSYCHOLOGY EVALUATION BUT WILL NOT USE THE COGNITIVE MOBILE TRAINING APPLICATION.
MOBILE COGNITIVE TRAINING APPExperimental
These patients will undergo neuropsychology evaluation and use the cognitive mobile training application
Devices: Cognitive training application
Sites
1 site in 1 country
- University of Alabama at BirminghamBirmingham, Alabama, United States